Welcome to our dedicated page for Atlas Lithium SEC filings (Ticker: ATLX), a comprehensive resource for investors and traders seeking official regulatory documents including 10-K annual reports, 10-Q quarterly earnings, 8-K material events, and insider trading forms.
Locating lithium reserve figures, modular plant cap-ex, and offtake agreements inside Atlas Lithium’s dense SEC disclosures can feel like panning for metal in miles of rock. Each 10-K alone mixes geologic jargon, environmental risk factors, and multi-currency project budgets—exactly the data serious investors need, but rarely have time to mine.
Stock Titan’s AI-powered analysis turns those sprawling documents into clear action points. Want Atlas Lithium insider trading Form 4 transactions as they hit EDGAR? Get real-time alerts. Need the latest Atlas Lithium quarterly earnings report 10-Q filing broken down into exploration spend, DMS plant progress, and cash runway? Our machine learning models surface the metrics in seconds. From Atlas Lithium 8-K material events explained to a fully linked archive of proxy statements covering executive compensation, every filing type is captured, time-stamped, and summarized—so you can focus on decisions, not decoding.
Use cases professionals rely on daily:
- Track Atlas Lithium Form 4 insider transactions real-time to gauge management’s conviction.
- Compare ore-grade updates across periods via our Atlas Lithium earnings report filing analysis.
- Review the Atlas Lithium annual report 10-K simplified for reserve revisions and modular plant timelines.
- Dive into the Atlas Lithium proxy statement executive compensation section with AI-generated highlights.
Whether you’re understanding Atlas Lithium SEC documents with AI for the first time or refining a lithium price model, Stock Titan delivers complete, current, and clearly explained filings—turning technical disclosures into strategic insight.
Atlas Lithium (ATLX) filed its Q2-25 Form 10-Q. The company remains pre-production, with only quartzite sales reported.
- Revenue: $31.8k in Q2 (-83% YoY); $57.0k YTD (-85% YoY).
- Net loss: Q2 �$6.3 m vs �$10.0 m LY; YTD �$16.5 m vs �$23.1 m, helped by lower stock-based comp and exploration spend.
- Cash & liquidity: Cash fell to $13.9 m (-$1.7 m YTD). Operating cash burn was $8.3 m; capex/exploration another $6.3 m, partly offset by $12.9 m raised via the Nov-24 ATM program (2.47 m shares).
- Balance sheet: Total assets $63.3 m (+9% YTD) driven by capex on Neves project. Equity rose to $26.2 m from $22.0 m. Convertible debt stable at $9.94 m (6.5% coupon, $28.225 conversion price).
- Dilution: Shares outstanding increased 18% to 18.8 m; 19.6 m as of 31-Jul-25.
- Derivative items: NDF hedge produced $0.43 m OCI gain; conversion-feature liability fell to $7k.
- Operational milestones: � Mining concession granted for core Neves right (1,536 ha). � Definitive Feasibility Study (issued 30-Jul-25) projects 146 ktpa spodumene, $57 m capex, after-tax IRR 145%, 11-month payback, cash cost $489/t (lowest quartile).
Outlook: Management touts strong DFS economics, but substantial funding will be required to cover the $57 m build-out while sustaining a high cash burn. Continued reliance on equity raises implies further dilution risk.
IonQ, Inc. (IONQ) � Form 4 Insider Transaction
Chief Financial Officer Thomas G. Kramer reported the sale of 43,382 shares of IonQ common stock on 07 July 2025 at a weighted-average price of $47.73 per share under a Rule 10b5-1 trading plan adopted on 14 March 2025. Following the transaction, Kramer’s direct holdings stand at 603,134 shares, with an additional 5 shares held indirectly for a child.
The disposition represents roughly 6-7 % of the executive’s pre-trade direct position and generated proceeds of approximately $2.1 million. No derivative security activity was reported. The filing indicates the transaction was executed as part of a pre-arranged plan, which can reduce signaling concerns but still reduces insider exposure to the stock.